Genentech sues Biogen for debt over blockbuster MS drug

Published Date: 08 Mar 2023

Roche's Genentech Inc sued Biogen MA Inc in federal court in San Francisco, alleging that Biogen owed additional patent royalties from worldwide sales of its blockbuster multiple sclerosis and Crohn's disease drug, Tysabri.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Breast cancer prevention: How nurse practitioners and physician assistants can help

2.

Utilizing cerium/lanthanum-134 to improve cancer detection and treatment.

3.

Ketamine plus psychotherapy for "excellent" PTSD

4.

Experts Discuss Groundbreaking Advances in EGFR-Mutant Lung Cancer

5.

a cutting-edge cancer diagnostic tool.


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot